Skip to content

Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain

Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07639060
Enrollment
80
Registered
2026-06-10
Start date
2026-06-20
Completion date
2028-07-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Causalgia, Cervical Spondylosis, Chronic Hip Pain, Chronic Low Back Pain, Chronic Neck Pain, Chronic Pain, Chronic Pain Syndrome, Hip Osteoarthritis, Knee Osteoarthritis, Lumbar Spondylosis, Occipital Neuralgia, PERIPHERAL NEUROPATHY, Shoulder Arthritis, Spasticity

Brief summary

To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chronic pain at Yale.

Interventions

None listed

Sponsors

Yale University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of chronic pain (generally pain duration of at least 3-6 months) localized to an anatomical region appropriate for cryoneurolysis as determined by the treating physician. * Planned cryoneurolysis procedure as part of standard clinical care. * Ability to provide written informed consent. * Ability and willingness to complete baseline and follow-up questionnaires.

Exclusion criteria

* Cryoneurolysis performed as part of a separate investigational trial in which data sharing is not permitted. * Active infection or other clinical contraindication to the procedure as determined by the treating clinician. * Life expectancy of less than 12 months in the judgment of the treating clinician. * Any condition that, in the investigator's opinion, would interfere with study participation or completion of follow-up, such as severe psychiatric instability or active substance use that precludes reliable follow-up

Design outcomes

Primary

MeasureTime frameDescription
Percentage of participants with improvement in pain6 and 12 monthsPercentage of participants achieving a clinically meaningful improvement in pain. Pain improvement measured as a ≥2-point reduction on the 0-10 Numeric Rating Scale (NRS). NRS is a widely used, validated 0-10, tool for measuring subjective pain intensity, where 0 represents "no pain" and 10 represents "the worst pain imaginable".
Change in Pain Disability Index (PDI) score6 and 12 monthsPDI is a 7-item self-report questionnaire used to measure how chronic pain interferes with various aspects of a person's life, with total scores ranging from 0 (no disability) to 70 (maximum disability).

Secondary

MeasureTime frameDescription
Number of pain-related hospital admissionsup to 12 months post cryoneurolysisNumber of pain-related hospital admissions in the 12 months before versus the 12 months after cryoneurolysis.
Number of pain-related emergency department visitsup to 12 months post cryoneurolysisNumber of pain-related emergency department visits in the 12 months before versus the 12 months after cryoneurolysis.
Number of pain-related medication refillsup to 12 months post cryoneurolysisNumber of pain-related medication refills in the 12 months before versus the 12 months after cryoneurolysis.
Number of responders6 and 12 monthResponders are participants reporting 'much improved' or 'very much improved' using the Patient Global Impression of Change (PGIC).

Countries

United States

Contacts

CONTACTCharles A Odonkor, MD
charles.odonkor@yale.edu203-767-1555
CONTACTMuhammad U Siddique, MD
muhammad.siddique@yale.edu
PRINCIPAL_INVESTIGATORCharles A Odonkor, MD

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026